Incheon Mayor Park Nam-chun is discussing the establishment of a raw material facility for biopharmaceuticals in Songdo with Joachim Kreutzberg, Chairman of the German Sartorius, at Songdo G Tower on the 25th. <br>[Photo by Incheon City]

Incheon Mayor Park Nam-chun is discussing the establishment of a raw material facility for biopharmaceuticals in Songdo with Joachim Kreutzberg, Chairman of the German Sartorius, at Songdo G Tower on the 25th.
[Photo by Incheon City]

View original image


[Asia Economy Reporter Park Hyesook] The Incheon Free Economic Zone Authority announced that on the 25th, Incheon Mayor Park Namchun met with Joachim Kreuzburg, chairman of Sartorius, a global German life sciences company, at G Tower in Songdo International City.


The meeting was held to discuss the follow-up progress and detailed plans after Sartorius signed an investment attraction agreement on the 3rd of this month with Incheon City and others for a $300 million investment in a biopharmaceutical raw material facility in Songdo International City.


Mayor Park stated, "Incheon Songdo is the best choice for Sartorius to establish a major production base in Asia," adding, "We will provide maximum support so that Songdo can become a global hub not only for biopharmaceutical production but also for raw material supply."


Last November, Sartorius submitted a letter of intent to the Incheon Free Economic Zone Authority for a $100 million facility investment to build biopharmaceutical raw material manufacturing, research and development, and educational facilities in Songdo.


Earlier this month, they signed a memorandum of understanding to expand the facility investment scale to $300 million together with the Ministry of Trade, Industry and Energy, Ministry of Health and Welfare, and Incheon City.


Founded in Germany in 1870, Sartorius is a global leading company in the bio research and process field, supplying products and equipment related to life sciences research and processes, and supporting related technical services. It operates branches in more than 60 countries, employs over 10,600 people, and recorded sales of 3.2 trillion KRW last year.


Sartorius plans to establish production facilities for single-use bags, cell culture media, pharmaceutical filters, membranes, and more in Songdo, developing it as a global export hub.



Additionally, they intend to promote research and development and educational projects in the biopharmaceutical process field, contributing to domestic technology transfer and the co-growth of related industries.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing